x
×
Venofer IV

Venofer IV

(Iron Sucrose Infusion Therapy)

Iron is one of the most fundamental nutrients in human physiology—essential for oxygen transport, energy production, immune function, and cognitive performance. When iron stores are depleted and oral supplementation is insufficient, poorly tolerated, or too slow to meet clinical need, intravenous iron sucrose (Venofer®) provides a direct, physician-supervised route to replenish iron levels. At The Longevity Center FL, Venofer IV infusions are administered under the direction of Dr. Benjamin Kosubevsky, with advanced training in Osteopathic, Regenerative, and Integrative Medicine, for patients in West Palm Beach and across South Florida with laboratory-confirmed iron deficiency.

Iron sucrose (Venofer) is an FDA-approved intravenous iron replacement product with over 70 years of clinical use and more than 25 million patient-years of worldwide clinical experience. It is one of the most extensively studied IV iron formulations available and has a well-characterized safety profile across multiple patient populations (Lopez et al., The Lancet, 2016).

Important Notice

Iron sucrose (Venofer®) is an FDA-approved prescription medication indicated for the treatment of iron deficiency anemia. At The Longevity Center FL, Venofer is administered only to patients with laboratory-confirmed iron deficiency, under physician supervision. This infusion requires pre-treatment laboratory evaluation and post-infusion monitoring. Iron sucrose is not appropriate for all patients, and it is not intended for use in patients with iron overload, hemochromatosis, or anemia not caused by iron deficiency. This service is not a substitute for evaluation by your primary care physician or hematologist. Potential risks include hypersensitivity reactions, hypotension, and other adverse effects; please review the full prescribing information with your physician.

Why Intravenous Iron?

Iron deficiency is among the most common nutritional deficiencies worldwide and a leading cause of anemia. A comprehensive review in the New England Journal of Medicine described iron deficiency anemia as a significant contributor to fatigue, impaired cognitive function, reduced exercise tolerance, and compromised immune response (Camaschella, NEJM, 2015). While oral iron supplementation is appropriate for many patients, intravenous administration may be clinically indicated when:

  • Oral iron is not tolerated due to gastrointestinal side effects (nausea, constipation, abdominal discomfort)
  • Oral iron has been tried for an adequate period without sufficient improvement in iron markers
  • Malabsorption conditions (such as inflammatory bowel disease, celiac disease, or post-surgical states) limit oral iron absorption
  • The degree of iron deficiency is significant enough that oral repletion would be impractically slow
  • A clinical situation requires more rapid iron repletion than oral supplementation can provide

Research has demonstrated that IV iron sucrose may be associated with more rapid and reliable increases in hemoglobin and iron stores compared to oral supplementation in certain patient populations (Van Wyck et al., Kidney International, 2005).

How It Works

Iron sucrose delivers iron directly into the bloodstream as an iron(III) hydroxide–sucrose complex. Following infusion, iron is rapidly taken up by the liver, spleen, and bone marrow, where the majority is utilized for red blood cell synthesis. Published pharmacokinetic data indicate that serum ferritin and transferrin saturation levels may begin to improve within 24 hours to one week following administration (Auerbach & Adamson, American Journal of Hematology, 2016).

What to Expect

Pre-Infusion Laboratory Evaluation

Before any Venofer infusion, Dr. Kosubevsky requires laboratory confirmation of iron deficiency. This typically includes a complete blood count (CBC), serum ferritin, transferrin saturation (TSAT), and serum iron. These values establish that iron deficiency is present and that IV iron replacement is clinically appropriate. Patients with evidence of iron overload, hemochromatosis, or anemia unrelated to iron deficiency are not candidates for this therapy.

The Infusion

Venofer is administered as a slow intravenous infusion in our clinic, typically over 15 to 30 minutes per dose. The total cumulative dose and number of infusion sessions are determined by Dr. Kosubevsky based on your laboratory values and clinical presentation. Most patients receive their infusion comfortably in one of our IV chairs.

Post-Infusion Monitoring

Patients are monitored for at least 30 minutes following each infusion to observe for any adverse reactions, including hypersensitivity or changes in blood pressure. Follow-up laboratory testing is performed after the treatment course is complete to evaluate response and determine whether additional infusions are needed.

Who This Therapy May Be Appropriate For

Persistent Fatigue with Confirmed Iron Deficiency

For patients whose laboratory values confirm depleted iron stores and who have not responded adequately to oral supplementation or who cannot tolerate it.

Women with Heavy Menstrual Cycles or Postpartum Iron Loss

Menstrual blood loss and the demands of pregnancy and postpartum recovery are among the most common causes of iron deficiency in women of reproductive age. IV iron may be appropriate when oral repletion is insufficient to keep pace with ongoing losses (Lopez et al., The Lancet, 2016).

Patients with Malabsorption or GI Conditions

For individuals with inflammatory bowel disease, celiac disease, gastric bypass history, or other gastrointestinal conditions that may impair oral iron absorption.

Pre-Surgical Iron Optimization

For patients preparing for elective surgery who have iron deficiency anemia and need to improve their hemoglobin levels before the procedure.

Athletes and Active Individuals with Documented Deficiency

Iron deficiency—even without overt anemia—has been associated with reduced work capacity and exercise performance in peer-reviewed research (Haas & Brownlie, Journal of Nutrition, 2001). For active individuals with lab-confirmed deficiency, IV iron may support more efficient repletion than oral supplementation alone.

Why Choose Dr. Kosubevsky?

Dr. Benjamin Kosubevsky combines conventional medical training with advanced experience in integrative, regenerative, and osteopathic medicine. For patients receiving Venofer IV therapy, Dr. Kosubevsky provides:

  • Lab-Confirmed Clinical Decision: Venofer is prescribed only after laboratory evaluation confirms iron deficiency. No patient receives IV iron without documented clinical indication.
  • Physician-Supervised Administration: All infusions are administered under direct physician supervision in our clinic, with appropriate monitoring during and after each session.
  • Integrated Wellness Context: Iron status is evaluated as part of your broader metabolic and nutritional picture. Dr. Kosubevsky considers how iron deficiency may interact with thyroid function, hormonal health, and other systems rather than addressing it in isolation.

Restore What Your Body Needs to Function

Iron deficiency is one of the most correctable contributors to fatigue, reduced exercise tolerance, and impaired daily function. When oral supplementation is not enough, Venofer IV at The Longevity Center FL offers a proven, physician-supervised pathway to replenish iron stores efficiently and safely.

Give Us a Call

+1 (561) 210-4033

Schedule your consultation to determine whether Venofer IV is clinically appropriate for you.

Schedule an Appointment

Medical Disclaimer

The information on this page is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Iron sucrose (Venofer®) is an FDA-approved prescription medication and is administered at The Longevity Center FL only under physician supervision for patients with laboratory-confirmed iron deficiency. This therapy is not appropriate for all patients and is not indicated for anemia not caused by iron deficiency, iron overload, or hemochromatosis. Serious adverse reactions, including hypersensitivity and hypotension, have been reported with IV iron products; patients are monitored during and after infusion. Individual results vary based on each patient’s health history, laboratory findings, and clinical presentation. This service is not a substitute for evaluation and care by your primary care physician or hematologist. Always consult a qualified healthcare professional regarding any medical condition, symptom, medication, or treatment decision. Peer-reviewed research cited on this page reflects population-level findings and does not predict individual outcomes.

 

References

1. Camaschella C. Iron-Deficiency Anemia. New England Journal of Medicine. 2015;372(19):1832-1843.
2. Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. The Lancet. 2016;387(10021):907-916.
3. Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. American Journal of Hematology. 2016;91(1):31-38.
4. Van Wyck DB, Roppolo M, Martinez CO, Mazey RM, McMurray S. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis- dependent CKD. Kidney International. 2005;68(6):2846-2856.
5. Haas JD, Brownlie T IV. Iron Deficiency and Reduced Work Capacity: A Critical Review of the Research to Determine a Causal Relationship. Journal of Nutrition. 2001;131(2):676S-690S.

Frequently Asked Questions

Venofer is an intravenous iron sucrose formulation used to treat iron deficiency anemia when oral iron is not tolerated, poorly absorbed, or insufficient to correct the deficit. It is commonly used for patients with low ferritin, documented anemia, fatigue, or hair loss related to iron deficiency. Unlike most therapies at the clinic, Venofer is an FDA-approved prescription medication used for its labeled indication. Dose is calculated based on your labs, weight, and the size of your iron deficit.

Blood testing showing low ferritin, low serum iron, low transferrin saturation, or frank anemia, combined with symptoms such as fatigue, shortness of breath, brittle nails, restless legs, or hair loss, may indicate a need for IV iron. Your provider reviews your labs and symptoms before recommending Venofer, and will typically investigate why you are deficient, since ongoing blood loss or malabsorption needs to be identified rather than just repleted.

Venofer is generally well tolerated and has a favorable safety profile compared with older IV iron formulations. Allergic and hypersensitivity reactions are rare but possible, so you are monitored closely during and after each infusion, and the clinic follows established protocols to manage any adverse reaction promptly. Patients with iron overload conditions such as hemochromatosis should not receive IV iron, which is why baseline testing is required.

Each infusion typically takes 30 minutes. Total visit time includes check-in, screening, and an observation period after the infusion, which is standard practice for IV iron. Plan for roughly 60 minutes overall. Your provider will confirm the expected duration and the number of infusions in your course when your care plan is created.

A typical course includes around five infusions given over two weeks, with repeat lab testing four to eight weeks afterward to confirm ferritin and hemoglobin have responded. The exact number depends on the size of your iron deficit, which is calculated from your weight and baseline labs. Some patients need an additional course if they have ongoing losses, such as heavy menstrual bleeding or gastrointestinal blood loss.

Possible side effects include headache, nausea, muscle or joint aches, metallic taste, flushing, and transient low blood pressure. Some patients experience mild flu-like symptoms for a day afterward. Serious hypersensitivity reactions are rare. Staining of the skin can occur if the IV infiltrates, which is why placement is checked carefully. The clinic monitors you during and after each infusion and provides clear aftercare guidance.

The clinic does not bill insurance for any service, so Venofer is self-pay here even though IV iron is often a covered benefit elsewhere. If cost is a concern and you have a documented deficiency, it is worth asking whether your primary care physician or a hematologist could administer it under your plan instead. The clinic will tell you honestly if that is the better route for your situation. Check with your plan administrator on whether HSA or FSA funds can be applied.

Oral iron is usually tried first and works well for many patients, so it is the appropriate starting point unless absorption is impaired, side effects are intolerable, or iron stores are severely depleted and need faster correction. Conditions such as celiac disease, inflammatory bowel disease, prior bariatric surgery, or chronic proton pump inhibitor use often limit oral absorption. Your provider will recommend the right route based on your labs, symptoms, and history.

Energy often improves within one to two weeks, with hemoglobin typically rising over four to eight weeks and ferritin stores rebuilding over several months. Symptoms such as hair shedding and restless legs may take longer to resolve. Repeat labs confirm whether you are responding as expected. Individual results vary depending on the severity of the deficiency and whether the underlying cause has been addressed.

Yes. Venofer is a prescription medication administered under medical supervision, and a documented diagnosis of iron deficiency with supporting lab work is required before therapy. The clinic will not administer IV iron without baseline testing, since giving iron to someone who is not deficient carries real risk of iron overload. Your provider determines the appropriate dose and schedule based on your evaluation.
Give Us a Call +1 (561) 210-4033

Schedule your appointment today and take the first step toward a healthier, more balanced life.

Schedule an Appointment